Syngene Archives - Express Pharma

Advantage India due to the Biosecure Act

Syngene secures silver rating in EcoVadis sustainability index, ranking in top 15% of assessed companies

Veeda Board appoints Dr Mahesh Bhalgat as Group CEO

Syngene to acquire multi-modal facility from Stelis Biopharma

Biocon Academy conducts graduation ceremony for 185 students across four programs

Syngene reports strong third quarter results

Syngene reports revenue from operations up eight per cent in Q1

Orphan drug development remains a specialised segment with limited players

Syngene reports 10 per cent growth in revenue from operations

The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company